- Home
- BWEN vs BRNS Comparison
BWEN vs BRNS Comparison
Compare BWEN & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- BRNS
- Stock Information
- Founded
- BWEN N/A
- BRNS 2016
- Country
- BWEN United States
- BRNS United Kingdom
- Employees
- BWEN N/A
- BRNS N/A
- Industry
- BWEN Industrial Machinery/Components
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- BWEN Industrials
- BRNS Health Care
- Exchange
- BWEN Nasdaq
- BRNS Nasdaq
- Market Cap
- BWEN 41.1M
- BRNS 36.0M
- IPO Year
- BWEN N/A
- BRNS 2021
- Fundamental
- Price
- BWEN $1.88
- BRNS $1.02
- Analyst Decision
- BWEN Strong Buy
- BRNS Strong Buy
- Analyst Count
- BWEN 3
- BRNS 1
- Target Price
- BWEN $4.50
- BRNS $3.00
- AVG Volume (30 Days)
- BWEN 79.6K
- BRNS 18.3K
- Earning Date
- BWEN 08-12-2025
- BRNS 08-07-2025
- Dividend Yield
- BWEN N/A
- BRNS N/A
- EPS Growth
- BWEN N/A
- BRNS N/A
- EPS
- BWEN N/A
- BRNS N/A
- Revenue
- BWEN $142,358,000.00
- BRNS $14,969,000.00
- Revenue This Year
- BWEN $7.86
- BRNS N/A
- Revenue Next Year
- BWEN $4.51
- BRNS N/A
- P/E Ratio
- BWEN N/A
- BRNS N/A
- Revenue Growth
- BWEN N/A
- BRNS 4381.74
- 52 Week Low
- BWEN $1.41
- BRNS $0.64
- 52 Week High
- BWEN $3.69
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- BWEN 56.23
- BRNS 57.82
- Support Level
- BWEN $1.84
- BRNS $0.90
- Resistance Level
- BWEN $1.96
- BRNS $1.10
- Average True Range (ATR)
- BWEN 0.07
- BRNS 0.06
- MACD
- BWEN -0.00
- BRNS 0.01
- Stochastic Oscillator
- BWEN 57.89
- BRNS 65.52
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.